The improvement in post-ischemic cardiac function by albiglutide may be via a direct inotropic effect on the heart with activation of GLP-1 receptor in the setting of cardiac dysfunction [7], [14], [32], or via an indirect effect secondary to its reduction in myocardial infarct size. This evidence concerns the gene GLP1R and myocardial infarction.